Meirav Kedmi

5PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Humoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2026
Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

|Feb 11, 2026
Nivolumab Maintenance for Aggressive B-Cell Lymphoma in Remission After First Line Therapy: A Phase 2 Clinical Trial.

Meirav Kedmi, Elena Ribakovsky, Tzvika Porges

|Aug 01, 2025
Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I/II study.

Ivetta Danylesko, Avichai Shimoni, Abraham Avigdor

|Nov 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell Lymphoma.

Meirav Kedmi, Elena Ribakovsy, Ohad Benjamini

|Jun 16, 2022
Identifying a malignant B-cell lymphoma clone in peripheral blood using immunoglobulin high-throughput sequencing and lineage tree analysis.

Meirav Kedmi, Hadas Neuman, Guy Bitansky

Pageof 1

Frequent Collaborators

1 joint publications

Ivetta Danylesko

1 joint publications

Avichai Shimoni

1 joint publications

Noga Shem-Tov

1 joint publications

Arnon Nagler